Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP477 | DOI: 10.1530/endoabs.37.EP477

1Endocrinology Department, Puerto Real University Hospital, Puerto Real, Cádiz, Spain; 2Obstetric and Gynecology Department, Puerto Real University Hospital, Puerto Real, Cádiz, Spain.


Objective: The aim of this study was to examine the impact of a web-based telemedicine system for monitoring glucose control in pregnant women with diabetes on health care visits, metabolic control and pregnancy outcomes.

Subjects and methods: A prospective, single-centre, and interventional study with two parallel groups was performed in Puerto Real University Hospital (Spain). Women were assigned to two different glucose monitoring groups: control group (CG) that was managed only by follow-up with the Gestational Diabetes Unit (GDU) and telemedicine group (TMG) that was monitored both by more spaced GDU visits and a web-based telemedicine system. The number of health care visits, degree of metabolic control and maternal and neonatal outcomes were evaluated.

Results: 104 pregnant women with diabetes (77 with gestational diabetes, 16 with type 1 diabetes, and 11 with type 2 diabetes) were included in the TMG (n=40) or in the CG (n=64). There were no significant differences in mean HbA1c level during pregnancy or after delivery, despite significantly lower number of visits to the GDU (3.2±2.3 vs 5.9±2.3 visits, P<0.001), nurse educator (1.7±1.3 vs 3.0±1.7 visits, P<0.001), and general practitioner (3.7±2.0 vs 4.9±2.8 visits, P<0.034) in the TMG. There were no significant differences between groups in maternal or neonatal outcomes.

Conclusions: Web-based telemedicine system can be a useful tool facilitating the management of pregnant diabetic patients, as a complement to conventional follow up and could contribute to reduce the outpatient clinic visits.

Article tools

My recent searches

No recent searches.

Authors